Lactate Dehydrogenase L-P, (LDH) (NAO), Catalog Number LD3842 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in serum and plasma. This product is suitable for use on the RX series instruments which includes the RX daytona and RX imola.
Published September 23, 2020 · Recall initiated: August 11, 2020
Summary
FDA records medical device Class II recall Z-2962-2020, published September 23, 2020 and initiated August 11, 2020. Recalling firm: Randox Laboratories Ltd.; Status: Terminated; Reported quantity: 21; Lot: GTIN: 05055273204124; Lot Numbers: 480483 495947 523902 536342. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Randox Laboratories Ltd.
- Distributor
- US Nationwide distribution including in the states of WV, and Puerto Rico.
- Lot
- GTIN: 05055273204124; Lot Numbers: 480483 495947 523902 536342
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Ireland
Related recalls
- FDARX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay onJuly 31, 2024
- FDAClinical Chemistry Calibration Serum (Catalog number Cal2351) that is 20x5ml lyophilized human based serumMay 15, 2024
- FDAEvidence MultiSTAT with software v 3.7-Analyzer intended for the qualitative determination of parent drugMay 15, 2024
- FDAMicroalbumin Calibrator Series (mALB CAL)-IVD used to calibrate the Microalbumin Assay Catalog Number: MA1567April 24, 2024
- FDAMaquet/Getinge Rotaflow System Console US (115 V / 60 Hz) - Product Usage: Instructions for Use - CentrifugalSeptember 23, 2020
- FDALactate Dehydrognease P-L, (UV), Catalog Number LD3818 - Product Usage: device intended for the quantitativeSeptember 23, 2020
Questions about this recall
Was Lactate Dehydrogenase L-P, (LDH) (NAO), Catalog Number LD3842 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in serum and plasma. This product is suitable for use on the RX series instruments which includes the RX daytona and RX imola. recalled?
Yes. FDA published recall Z-2962-2020 on September 23, 2020. Reported hazard: An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter